New score could spare epilepsy patients from invasive brain probes

NCT ID NCT06138808

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at whether a simple scoring system, called the 5-SENSE score, can accurately predict where seizures begin in the brain. Researchers will test this in 400 people with hard-to-treat epilepsy who are already scheduled for an invasive brain test called SEEG. If the score works well, it may help some patients avoid this risky procedure in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY INTRACTABLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Drug Resistant Epilepsy epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • "Carol Davila" University of Medicine and Pharmacy

    Bucharest, Romania

  • Alfred Health

    Melbourne, Australia

  • Christian Doppler University Hospital Paracelsus Medical University Salzburg and Centre for Cognitive Neuroscience Salzburg

    Salzburg, 5020, Austria

  • Dalhousie Universiry and Hospital

    Dalhousie, Nova Scotia, Canada

  • Danish Epilepsy Centre, Aarhus Universitets Hospital

    Aarhus, 8200, Denmark

  • Department of Clinical Neurosciences chez CHUV; Centre Hospitalier Universitaire Vaudois

    Lausanne, Switzerland

  • Departmet of Neurology, Masaryk University Brno

    Brno, Czechia

  • Duke University Health System

    Durham, North Carolina, 27710, United States

  • Epilepsy Centre, University Hospital Freiburg

    Freiburg im Breisgau, Germany

  • Epilepsy Department University Hospitals of Marseille

    Marseille, France

  • Grenoble Institute of Neurosciences, Centre Hospitalier Universitaire Grenoble Alpes

    Grenoble, France

  • Hospital Universitario y Politecnico La Fe

    Valencia, Spain

  • Mater Health

    Brisbane, Australia

  • Monash University

    Melbourne, Victoria, 3800, Australia

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • Presbyterian-Shadyside Hospital

    Pittsburgh, Pennsylvania, 15232, United States

  • University School of Medicine Kyoto

    Kyoto, 606-8303, Japan

  • University of Florida College of Medicine

    Gainesville, Florida, 32610, United States

  • Wester University

    London, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.